{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:35:40Z","timestamp":1786448140186,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015042","name":"R\u012bgas Stradi\u0146a Universit\u0101te","doi-asserted-by":"publisher","award":["RSU-ZG-2024\/1-0036"],"award-info":[{"award-number":["RSU-ZG-2024\/1-0036"]}],"id":[{"id":"10.13039\/501100015042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53560-x","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:13:52Z","timestamp":1780132432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of the first myasthenia gravis patient registry in Latvia: a single-centre experience"],"prefix":"10.1038","volume":"16","author":[{"given":"Arta","family":"Grosmane-Bataraga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimirs","family":"Krutovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Roddate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"\u017dukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gundega","family":"\u0136au\u0137e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieva","family":"Gl\u0101zere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Gail\u012bte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u013cja","family":"Kurj\u0101ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktorija","family":"\u0136\u0113ni\u0146a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"26","key":"53560_CR1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMRA1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus, N. E. Myasthenia gravis. N. Engl. J. Med. 375(26), 2570\u20132581. https:\/\/doi.org\/10.1056\/NEJMRA1602678 (2016).","journal-title":"N. Engl. J. Med."},{"key":"53560_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/J.JNS.2022.120268\/ATTACHMENT\/25F60214-EEB8-4B4B-AD20-CE4D014F37FC\/MMC1.DOCX","volume":"437","author":"D Gelinas","year":"2022","unstructured":"Gelinas, D. et al. The humanistic burden of myasthenia gravis: A systematic literature review. J Neurol Sci. 437, 120268. https:\/\/doi.org\/10.1016\/J.JNS.2022.120268\/ATTACHMENT\/25F60214-EEB8-4B4B-AD20-CE4D014F37FC\/MMC1.DOCX (2022).","journal-title":"J Neurol Sci."},{"issue":"1","key":"53560_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-91372-7","volume":"15","author":"S Lehnerer","year":"2025","unstructured":"Lehnerer, S. et al. The economic burden of Myasthenia gravis from the patient\u00b4s perspective and reflected in German claims data. Sci. Rep. 15(1), 1\u201313. https:\/\/doi.org\/10.1038\/s41598-025-91372-7 (2025).","journal-title":"Sci. Rep."},{"issue":"10","key":"53560_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3\/ASSET\/26102514-F014-48AB-9077-4ABFDBF8A652\/MAIN.ASSETS\/GR5.SML","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus, N. E. & Verschuuren, J. J. Myasthenia gravis: Subgroup classification and therapeutic strategies. Lancet Neurol. 14(10), 1023\u20131036. https:\/\/doi.org\/10.1016\/S1474-4422(15)00145-3\/ASSET\/26102514-F014-48AB-9077-4ABFDBF8A652\/MAIN.ASSETS\/GR5.SML (2015).","journal-title":"Lancet Neurol."},{"issue":"5","key":"53560_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/WCO.0000000000000473","volume":"30","author":"A Evoli","year":"2017","unstructured":"Evoli, A. Myasthenia gravis: New developments in research and treatment. Curr. Opin. Neurol. 30(5), 464\u2013470. https:\/\/doi.org\/10.1097\/WCO.0000000000000473 (2017).","journal-title":"Curr. Opin. Neurol."},{"key":"53560_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.832063\/BIBTEX","volume":"13","author":"S K\u00f6lker","year":"2022","unstructured":"K\u00f6lker, S., Gleich, F., M\u00fctze, U. & Opladen, T. Rare disease registries are key to evidence-based personalized medicine: Highlighting the European experience. Front Endocrinol (Lausanne) 13, 832063. https:\/\/doi.org\/10.3389\/FENDO.2022.832063\/BIBTEX (2022).","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"53560_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/S13023-023-02719-0\/TABLES\/2","volume":"18","author":"IC Hageman","year":"2023","unstructured":"Hageman, I. C., van Rooij, I. A. L. M., de Blaauw, I., Trajanovska, M. & King, S. K. A systematic overview of rare disease patient registries: Challenges in design, quality management, and maintenance. Orphanet J. Rare Dis. 18(1), 106. https:\/\/doi.org\/10.1186\/S13023-023-02719-0\/TABLES\/2 (2023).","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"53560_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.NRLENG.2014.09.010","volume":"32","author":"JM Aragon\u00e8s","year":"2017","unstructured":"Aragon\u00e8s, J. M. et al. Prevalence of Myasthenia gravis in the Catalan county of Osona. Neurolog\u00eda (English Edition) 32(1), 1\u20135. https:\/\/doi.org\/10.1016\/J.NRLENG.2014.09.010 (2017).","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"7","key":"53560_CR9","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/ENE.12703","volume":"22","author":"A Ramos-Fransi","year":"2015","unstructured":"Ramos-Fransi, A. et al. Myasthenia gravis: Descriptive analysis of life-threatening events in a recent nationwide registry. Eur. J. Neurol. 22(7), 1056\u20131061. https:\/\/doi.org\/10.1111\/ENE.12703 (2015).","journal-title":"Eur. J. Neurol."},{"key":"53560_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12731","author":"S Suzuki","year":"2022","unstructured":"Suzuki, S. et al. Japan MG registry: Chronological surveys over 10 years. Published online https:\/\/doi.org\/10.1111\/cen3.12731 (2022).","journal-title":"Published online"},{"key":"53560_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116830","author":"R Anil","year":"2020","unstructured":"Anil, R. et al. Exploring outcomes and characteristics of myasthenia gravis: Rationale, aims and design of registry \u2013 The EXPLORE-MG registry. J. Neurol. Sci. https:\/\/doi.org\/10.1016\/j.jns.2020.116830 (2020).","journal-title":"J. Neurol. Sci."},{"key":"53560_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.nmd.2021.05.006","volume":"31","author":"AM Ruiter","year":"2021","unstructured":"Ruiter, A. M. et al. Accuracy of patient-reported data for an online patient registry of autoimmune Myasthenia gravis and Lambert-Eaton myasthenic syndrome. Neuromuscul. Disord. 31, 622\u2013632. https:\/\/doi.org\/10.1016\/j.nmd.2021.05.006 (2021).","journal-title":"Neuromuscul. Disord."},{"key":"53560_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26695","author":"G Cutter","year":"2019","unstructured":"Cutter, G. et al. Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment. Muscle Nerve https:\/\/doi.org\/10.1002\/mus.26695 (2019).","journal-title":"Muscle Nerve"},{"key":"53560_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/MUS.28450","volume":"0","author":"KA Buzzard","year":"2025","unstructured":"Buzzard, K. A. et al. MGBase: A global, observational registry for collaborative research in Myasthenia Gravis. Muscle Nerve 0, 1\u20139. https:\/\/doi.org\/10.1002\/MUS.28450 (2025).","journal-title":"Muscle Nerve"},{"issue":"1","key":"53560_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13023-024-03520-3\/TABLES\/3","volume":"20","author":"A Slioui","year":"2025","unstructured":"Slioui, A. et al. Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data. Orphanet J. Rare Dis. 20(1), 1\u201313. https:\/\/doi.org\/10.1186\/S13023-024-03520-3\/TABLES\/3 (2025).","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"53560_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-025-04558-z","volume":"12","author":"ASL Graefe","year":"2025","unstructured":"Graefe, A. S. L. et al. An ontology-based rare disease common data model harmonising international registries, FHIR, and Phenopackets. Sci. Data 12(1), 234. https:\/\/doi.org\/10.1038\/s41597-025-04558-z (2025).","journal-title":"Sci. Data"},{"key":"53560_CR17","doi-asserted-by":"publisher","unstructured":"Jaretzki A, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000;55(1):16\u201323. https:\/\/doi.org\/10.1212\/WNL.55.1.16","DOI":"10.1212\/WNL.55.1.16"},{"issue":"18","key":"53560_CR18","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1212\/WNL.0B013E3181DC1B1E","volume":"74","author":"TM Burns","year":"2010","unstructured":"Burns, T. M., Conaway, M. & Sanders, D. B. The MG Composite: A valid and reliable outcome measure for myasthenia gravis. Neurology 74(18), 1434\u20131440. https:\/\/doi.org\/10.1212\/WNL.0B013E3181DC1B1E (2010).","journal-title":"Neurology"},{"issue":"7","key":"53560_CR19","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","volume":"52","author":"GI Wolfe","year":"1999","unstructured":"Wolfe, G. I. et al. Myasthenia gravis activities of daily living profile. Neurology 52(7), 1487\u20131487. https:\/\/doi.org\/10.1212\/WNL.52.7.1487 (1999).","journal-title":"Neurology"},{"issue":"1","key":"53560_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/MUS.21883","volume":"43","author":"TM Burns","year":"2011","unstructured":"Burns, T. M., Grouse, C. K., Wolfe, G. I., Conaway, M. R. & Sanders, D. B. The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis. Muscle Nerve 43(1), 14\u201318. https:\/\/doi.org\/10.1002\/MUS.21883 (2011).","journal-title":"Muscle Nerve"},{"issue":"10","key":"53560_CR21","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/ARCHNEUR.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp, L. B., Larocca, N. G., Muir Nash, J. & Steinberg, A. D. The Fatigue Severity Scale: Application to patients with Multiple Sclerosis and Systemic Lupus Erythematosus. Arch. Neurol. 46(10), 1121\u20131123. https:\/\/doi.org\/10.1001\/ARCHNEUR.1989.00520460115022 (1989).","journal-title":"Arch. Neurol."},{"issue":"1","key":"53560_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus, N. E. et al. Myasthenia gravis. Nat. Rev. Dis. Primers 5(1), 30. https:\/\/doi.org\/10.1038\/s41572-019-0079-y (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"53560_CR23","unstructured":"How Engage works. Accessed August 6, 2025. https:\/\/engagehelp.longenesis.com\/how-engage-works"},{"issue":"01","key":"53560_CR24","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.21474\/IJAR01\/12392","volume":"9","author":"M Aziz","year":"2021","unstructured":"Aziz, M., Khan, A. J. & Khan, S. Rare disease registries-purpose, challenges & solutions. Int. J. Adv. Res. 9(01), 1074\u20131078. https:\/\/doi.org\/10.21474\/IJAR01\/12392 (2021).","journal-title":"Int. J. Adv. Res."},{"key":"53560_CR25","doi-asserted-by":"publisher","unstructured":"Grosmane A, Roze I, Roddate M, et al. Translation and validation of the Myasthenia Gravis Activities of Daily Living Questionnaire: Latvian version. Frontiers in Neurology . 2024;15. https:\/\/doi.org\/10.3389\/FNEUR.2024.1397603\/FULL","DOI":"10.3389\/FNEUR.2024.1397603\/FULL"},{"key":"53560_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110564","author":"AK Bhandage","year":"2024","unstructured":"Bhandage, A. K. et al. Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls. iScience https:\/\/doi.org\/10.1016\/j.isci.2024.110564 (2024).","journal-title":"iScience"},{"key":"53560_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02727-0","volume":"18","author":"M Mahic","year":"2023","unstructured":"Mahic, M. et al. Physician-and patient-reported perspectives on myasthenia gravis in Europe: A real-world survey. Orphanet J. Rare Dis. 18, 169. https:\/\/doi.org\/10.1186\/s13023-023-02727-0 (2023).","journal-title":"Orphanet J. Rare Dis."},{"issue":"12","key":"53560_CR28","doi-asserted-by":"publisher","first-page":"S468","DOI":"10.1016\/j.jval.2022.09.2329","volume":"25","author":"A Borsi","year":"2022","unstructured":"Borsi, A. et al. RWD104 delayed diagnosis amongst gMG patients: Results from a European real-world study. Value Health 25(12), S468\u2013S469. https:\/\/doi.org\/10.1016\/j.jval.2022.09.2329 (2022).","journal-title":"Value Health"},{"key":"53560_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/BMJNO-2025-001441","author":"ER Koc","year":"2025","unstructured":"Koc, E. R. et al. Determinants of health literacy and its impact on illness perception in patients with multiple sclerosis: Evidence from patient-reported outcomes. BMJ. Neurol. Open https:\/\/doi.org\/10.1136\/BMJNO-2025-001441 (2025).","journal-title":"BMJ. Neurol. Open"},{"key":"53560_CR30","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119865647","author":"H Ueno","year":"2019","unstructured":"Ueno, H. et al. The association between health literacy levels and patient-reported outcomes in Japanese type 2 diabetic patients. SAGE Open Med. https:\/\/doi.org\/10.1177\/2050312119865647 (2019).","journal-title":"SAGE Open Med."},{"issue":"9","key":"53560_CR31","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/S11606-015-3329-Z","volume":"30","author":"HS Yin","year":"2015","unstructured":"Yin, H. S., Jay, M., Maness, L., Zabar, S. & Kalet, A. Health literacy: An educationally sensitive patient outcome. J. Gen. Intern. Med. 30(9), 1363\u20131368. https:\/\/doi.org\/10.1007\/S11606-015-3329-Z (2015).","journal-title":"J. Gen. Intern. Med."},{"key":"53560_CR32","doi-asserted-by":"publisher","unstructured":"Jing S, Zhang Z, Zhou Y, et al. Predictors of Quality of Life in Myasthenia Gravis Patients from Southwestern China: Validation of Clinical and Socioenvironmental Determinants. Neuroepidemiology. Published online 2025:1\u201311. https:\/\/doi.org\/10.1159\/000548274","DOI":"10.1159\/000548274"},{"key":"53560_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2020.553626\/FULL","volume":"11","author":"P Szczudlik","year":"2020","unstructured":"Szczudlik, P. et al. Determinants of quality of life in myasthenia gravis patients. Front. Neurol. 11, 553626. https:\/\/doi.org\/10.3389\/FNEUR.2020.553626\/FULL (2020).","journal-title":"Front. Neurol."},{"key":"53560_CR34","doi-asserted-by":"publisher","unstructured":"Dunand M, Botez SA, Fran\u00e7ois-Xavier AE, et al. Unsatisfactory outcomes in myasthenia gravis: influence by care providers. https:\/\/doi.org\/10.1007\/s00415-009-5318-9","DOI":"10.1007\/s00415-009-5318-9"},{"key":"53560_CR35","doi-asserted-by":"publisher","first-page":"175628642312132","DOI":"10.1177\/17562864231213240","volume":"16","author":"H Wiendl","year":"2023","unstructured":"Wiendl, H. et al. Guideline for the management of myasthenic syndromes. Ther Adv Neurol Disord. 16, 17562864231213240. https:\/\/doi.org\/10.1177\/17562864231213240 (2023).","journal-title":"Ther Adv Neurol Disord."},{"key":"53560_CR36","doi-asserted-by":"publisher","unstructured":"Funke M, Eveslage M, Zsch\u00fcntzsch J, et al. Fatigue and associated factors in myasthenia gravis: a nationwide registry study. J Neurol. 123AD;271:5665\u20135670. https:\/\/doi.org\/10.1007\/s00415-024-12490-2","DOI":"10.1007\/s00415-024-12490-2"},{"key":"53560_CR37","doi-asserted-by":"publisher","unstructured":"Ruiter AM, Verschuuren JJGM, Tannemaat MR. Fatigue in patients with myasthenia gravis. A systematic review of the literature. Published online 2020. https:\/\/doi.org\/10.1016\/j.nmd.2020.06.010","DOI":"10.1016\/j.nmd.2020.06.010"},{"issue":"4","key":"53560_CR38","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/S13760-022-01919-Y","volume":"122","author":"SA Akkan","year":"2022","unstructured":"Akkan, S. A., Kahraman, K. P., Uluc, K. & Tanridag, T. Physical and mental fatigue in Myasthenia Gravis and its correlation with other symptoms. Acta Neurol. Belg. 122(4), 915\u2013923. https:\/\/doi.org\/10.1007\/S13760-022-01919-Y (2022).","journal-title":"Acta Neurol. Belg."},{"issue":"10","key":"53560_CR39","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/S00415-018-8995-4\/METRICS","volume":"265","author":"TM Alekseeva","year":"2018","unstructured":"Alekseeva, T. M. et al. Fatigue in patients with Myasthenia Gravis. J. Neurol. 265(10), 2312\u20132321. https:\/\/doi.org\/10.1007\/S00415-018-8995-4\/METRICS (2018).","journal-title":"J. Neurol."},{"issue":"1","key":"53560_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/S12967-023-03887-0","volume":"21","author":"S Rasa-Dzelzkaleja","year":"2023","unstructured":"Rasa-Dzelzkaleja, S. et al. The persistent viral infections in the development and severity of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. J. Transl. Med. 21(1), 33. https:\/\/doi.org\/10.1186\/S12967-023-03887-0 (2023).","journal-title":"J. Transl. Med."},{"issue":"1","key":"53560_CR41","doi-asserted-by":"publisher","DOI":"10.1159\/000517930","volume":"65","author":"SH Mozhgani","year":"2021","unstructured":"Mozhgani, S. H. et al. Human Herpesvirus 6 infection and risk of Chronic Fatigue Syndrome: A systematic review and meta-analysis. Intervirology 65(1), 49. https:\/\/doi.org\/10.1159\/000517930 (2021).","journal-title":"Intervirology"},{"issue":"1","key":"53560_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13023-022-02489-1\/METRICS","volume":"17","author":"JP Marques","year":"2022","unstructured":"Marques, J. P. et al. Challenges, facilitators and barriers to the adoption and use of a web-based national IRD registry: Lessons learned from the IRD-PT registry. Orphanet J. Rare Dis. 17(1), 1\u20134. https:\/\/doi.org\/10.1186\/S13023-022-02489-1\/METRICS (2022).","journal-title":"Orphanet J. Rare Dis."},{"issue":"22","key":"53560_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/IJERPH182211968","volume":"18","author":"SR Ali","year":"2021","unstructured":"Ali, S. R. et al. The quality evaluation of rare disease registries\u2014An assessment of the essential features of a disease registry. Int. J. Environ. Res. Public Health 18(22), 11968. https:\/\/doi.org\/10.3390\/IJERPH182211968 (2021).","journal-title":"Int. J. Environ. Res. Public Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53560-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:04:45Z","timestamp":1786446285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53560-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53560"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53560-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Research Ethics Committee of R\u012bga Stradi\u0146\u0161 University (approval number: 2-P\u0112K-4\/70\/2023, date: 10 January 2023). Written informed consent was obtained from all participants before their inclusion in the study, in accordance with the relevant ethical standards.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24764"}}